GLB1 and prostate carcinoma: Lysosomal β-galactosidase (GLB1) hydrolyzed β-galactosidase from a sugar conjugate, representing the origin of the aging-associated β-galactosidase SA-SS-GAL, was reported to be a reliable biomarker of aging in prostate cancer (61).